{"id":11035,"date":"2003-05-01T13:13:24","date_gmt":"2003-05-01T13:13:24","guid":{"rendered":"http:\/\/i-base.info\/htb\/?p=11035"},"modified":"2003-05-01T13:13:24","modified_gmt":"2003-05-01T13:13:24","slug":"newsletters-and-journals-iapac-monthly-aids-treatment-news-step-perspective-prn-notebook-hopkins-hiv-report-ghmc-treatment-issues-tag-line","status":"publish","type":"post","link":"https:\/\/i-base.info\/htb\/11035","title":{"rendered":"Newsletters and journals: IAPAC Monthly, AIDS Treatment News, STEP Perspective, PRN Notebook, Hopkins HIV Report, GHMC Treatment Issues, TAG Line"},"content":{"rendered":"<h2>IAPAC Monthly February 2003<\/h2>\n<p><a href=\"http:\/\/www.iapac.org\/iapacmonthly.asp?catid=14\"> http:\/\/www.iapac.org\/iapacmonthly.asp?catid=14<\/a><\/p>\n<ul>\n<li> Report from the President &#8211; Hope for turning of the tide<\/li>\n<li> Needed: Committed and daring voices<\/li>\n<li> HIV care in 2003: A viewpoint<\/li>\n<li> Will AIDS finally teach us the meaning of sustainable human development (for all)?<\/li>\n<\/ul>\n<h2>AIDS Treatment News \u2013 April 4, 2003<\/h2>\n<p>Including an interview with Cal Cohen MD Part Two<\/p>\n<p><a href=\"http:\/\/www.aids.org\/immunet\/atn.nsf\/page\/i-latest\"> http:\/\/www.aids.org\/immunet\/atn.nsf\/page\/i-latest<\/a><\/p>\n<h2>STEP Perspective &#8211; Winter 2002\/2003<\/h2>\n<p><a href=\"http:\/\/www.thebody.com\/step\/winter03\/contents.html\"> http:\/\/www.thebody.com\/step\/winter03\/contents.html<\/a><\/p>\n<p>Including:<\/p>\n<p><strong>Methadone and HIV Medications: Drug Interactions<\/strong><br \/>\nBarb Falkner, B.Sc. (Pharm.) and Bradley Kosel, Pharm.D.<br \/>\nfrom Seattle Treatment Education Project &#8211; Winter 2002\/2003<br \/>\n<a href=\"http:\/\/www.thebody.com\/step\/winter03\/methadone.html\">http:\/\/www.thebody.com\/step\/winter03\/methadone.html<\/a><\/p>\n<p><strong>Depression and HIV in the Era of HAART<\/strong><br \/>\nBy Andrew Elliott, M.D., M.P.H.<br \/>\n<a href=\"http:\/\/www.thebody.com\/step\/winter03\/depression.html\"> http:\/\/www.thebody.com\/step\/winter03\/depression.html<\/a><\/p>\n<h2>The PRN Notebook \u2013 March 2003<\/h2>\n<p>The March 2003 issue of The PRN Notebook is available online in both HTML and PDF formats.<\/p>\n<p><a href=\"http:\/\/www.prn.org\/\"> http:\/\/www.prn.org\/<\/a><\/p>\n<p><strong>2003 Review of experimental antiretrovirals<\/strong><br \/>\nScott M. Hammer, MD and Harold C. Neu<\/p>\n<p><strong>Metabolic and morphologic complications in HIV disease: Whats new?<\/strong><br \/>\nKathleen Mulligan, PhD and Donald P. Kotler, MD<\/p>\n<p><strong>Youth and HIV: the epidemic continues<\/strong><br \/>\nDonna Futterman, MD<\/p>\n<p><strong>Identifying HIV treatment and research priorities in resource-poor settings<\/strong><br \/>\nMiriam Rabkin, MD, MPH<\/p>\n<h2>Hopkins HIV Report \u2013 March 2003<\/h2>\n<p><a href=\"http:\/\/www.hopkins-aids.edu\/publications\/report\/report_toc_03.html\"> http:\/\/www.hopkins-aids.edu\/publications\/report\/report_toc_03.html<\/a><\/p>\n<ul>\n<li> Treatment Interruption<\/li>\n<li> Treatment of Tuberculosis in the HIV-Infected Patient<\/li>\n<li> Immune-Based Therapy in HIV<\/li>\n<li> When to Start HAART, and What to Start<\/li>\n<li> Taking HAART to Heart: Antiretroviral Toxicities<\/li>\n<li> Drug Resistance and Treatment of Experienced Patients<\/li>\n<li> HIV and Hepatitis<\/li>\n<\/ul>\n<h2>GHMC Treatment Issues \u2013 March 2003<\/h2>\n<p><a href=\"http:\/\/www.gmhc.org\/living\/treatment\/ti1703\/ti1703.html\"> http:\/\/www.gmhc.org\/living\/treatment\/ti1703\/ti1703.html<\/a><\/p>\n<p>Contents include:<\/p>\n<ul>\n<li>Long Path to Approval -A look back at the road to T-20<\/li>\n<li>Fuzeon Data Review &#8211; A capsule review of T-20 efficacy data together with TAG position paper<\/li>\n<li>$15 Million for Infrastructure but No AIDS Drugs for Jamaica &#8211; Richard Stern<\/li>\n<li>International Treatment Preparedness Summit Opens<\/li>\n<li>It\u2019s Time to Face the Zerit Problem- Nelson Vergel asks for caution on d4T<\/li>\n<\/ul>\n<h2>TAGline &#8211; April 2003<\/h2>\n<p><a href=\"http:\/\/www.thebody.com\/tag\/tagix.html\"> http:\/\/www.thebody.com\/tag\/tagix.html<\/a><\/p>\n<ul>\n<li> Full Count: Roche Tempts Fate With High Profile T-20 Launch<\/li>\n<li> Tipping Point: MSF, Oxfam Redefine the Possible, and Y2K Activist Trek to Durban Marks a Watershed<\/li>\n<li> TAG at Ten: The Year 2001<\/li>\n<\/ul>\n","protected":false},"excerpt":{"rendered":"<p>IAPAC Monthly February 2003 http:\/\/www.iapac.org\/iapacmonthly.asp?catid=14 Report from the President &#8211; Hope for turning of the tide Needed: Committed and daring voices HIV care in 2003: A viewpoint Will AIDS finally teach us the meaning of sustainable human development (for all)? &hellip;<\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"open","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[30],"tags":[],"class_list":["post-11035","post","type-post","status-publish","format-standard","hentry","category-on-the-web"],"_links":{"self":[{"href":"https:\/\/i-base.info\/htb\/wp-json\/wp\/v2\/posts\/11035","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/i-base.info\/htb\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/i-base.info\/htb\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/i-base.info\/htb\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/i-base.info\/htb\/wp-json\/wp\/v2\/comments?post=11035"}],"version-history":[{"count":0,"href":"https:\/\/i-base.info\/htb\/wp-json\/wp\/v2\/posts\/11035\/revisions"}],"wp:attachment":[{"href":"https:\/\/i-base.info\/htb\/wp-json\/wp\/v2\/media?parent=11035"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/i-base.info\/htb\/wp-json\/wp\/v2\/categories?post=11035"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/i-base.info\/htb\/wp-json\/wp\/v2\/tags?post=11035"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}